Physician Education: Bridging Clinical Research and Patient Care

Faculty Profile

Professor of Pathology and Laboratory Medicine
Georgia Research Alliance Eminent Scholar
Emory University
Atlanta, GA

Topics of Professional Interest:
  • HIV entry
  • Retrovirus assembly
Current Professional Summary:

Dr Hunter is a Professor of Microbiology and Medicine at the University of Alabama at Birmingham. He has served as Director of the UAB Center for AIDS Research for the past 12 years. Dr Hunter teaches courses in virology to both graduate and professional students.

Committees and Organizations:
  • Member, American Society of Virology
  • Member, International Society for Antiviral Research
  • Member, American Association for Cancer Research
  • Member, American Society for Biochemistry and Molecular Biology
  • Chair, Research Committee, Governor of Alabama's Commission on AIDS
Honors and Awards:
  • Editor-in-Chief, AIDS Research and Human Retroviruses (2000–)
  • Associate Editor, Virology (1985–)
  • Recipient of three National Institutes of Health MERIT Awards
Education:
  • University of Birmingham, England, Bacteriology, BSc with Honors (1989)
  • Imperial Cancer Research Fund & Brunel University of England, Tumor Immunology, PhD (1972)
  • University of Southern California, Postdoctoral Fellow, RNA Tumor Viruses (1972–1976)
Selected Publications:
  1. Sakalian M, Parker SD, Weldon RA Jr, Hunter E. Synthesis and assembly of retrovirus gag precursors into immature capsids in vitro. J Virol. 1996;70:3706-3715.
  2. Weldon RA Jr, Parker WB, Sakalian M, Hunter E. Type D retrovirus capsid assembly and release are active events requiring ATP. J Virol. 1998;72:3098-3106.
  3. Yasuda J, Hunter E. A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release. J Virol. 1998;72:4095-4103.
  4. Salzwedel K, West KT Jr, Mulligan MJ, Hunter E. Retention of the HIV-1 envelope glycoprotein in the endoplasmic reticulum does not redirect virus assembly from the plasma membrane. J Virol. 1998;72:7523-7531.
  5. Kilby JM, Hopkins S, Venetta TM, DiMassimo B, Cloud GA, Lee JY, Alldredge L, Hunter E, Lambert D, Bolognesi D, Matthews T, Johnson MR, Nowak MA, Shaw GM, Saag MS. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med. 1998;4:1302-1307.
  6. Salzwedel K, West JT, Hunter E. A conserved tryptophan-rich motif in the membrane-proximal region of the HIV-1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity. J Virol. 73:2469-2480.
  7. Choi G, Park S, Choi B, Hong S, Lee J, Hunter E, Rhee S. Identification of a cytoplasmic targeting/retention signal in a retroviral Gag Polyprotein. J Virol. 1999;73:5431-5437.
  8. Rumlova-Klikova M, Pichova I, Hunter E, Ruml T. Conditions resulting in formation of properly assembled retroviral capsids within inclusion bodies of Escherichia coli. Collect Czech Chem Commun. 1999;64:1348-1356.
  9. Derdeyn CA, Decker JM, Sfakianos JN, Wu X, O'Brien WA, Ratner L, Kappes JC, Shaw GM, Hunter E. Sensitivity of HIV-1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol. 2000;74:8358-8367.
  10. Piller SC, Dubay JW, Derdeyn CA, Hunter E. Mutational analysis of conserved domains within the cytoplasmic tail of gp-41 from HIV-1: effects on glycoprotein incorporation and infectivity. J Virol. 2000;74:11717-11723.